Exeter Financial, LLC Gsk PLC Transaction History

Exeter Financial, LLC

$222 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$42.05 - $47.77 $81,997 - $93,151	1,950 Added 4.63%	44,040 $1.92 Million
Q1 2022 Apr 27, 2022	BUY	$40.23 - $47.74 $167,195 - $198,407	4,156 Added 10.96%	42,090 $1.83 Million
Q4 2021 Jan 25, 2022	BUY	$38.88 - $45.31 $165,240 - $192,567	4,250 Added 12.62%	37,934 $1.7 Million
Q3 2021 Oct 22, 2021	SELL	$38.79 - $43.16 $2,172 - $2,416	-56 Reduced 0.17%	33,684 $1.29 Million
Q2 2021 Jul 30, 2021	BUY	$36.52 - $41.46 $16,799 - $19,071	460 Added 1.38%	33,740 $1.36 Million
Q1 2021 Apr 30, 2021	BUY	$34.27 - $40.01 $36,497 - $42,610	1,065 Added 3.31%	33,280 $1.19 Million
Q3 2020 Oct 08, 2020	BUY	$38.11 - $42.99 $3,811 - $4,299	100 Added 0.31%	32,215 $1.21 Million
Q2 2020 Jul 21, 2020	SELL	$37.87 - $43.58 $78,239 - $90,036	-2,066 Reduced 6.04%	32,115 $1.31 Million
Q1 2020 Apr 23, 2020	BUY	$32.47 - $48.83 $76,564 - $115,141	2,358 Added 7.41%	34,181 $1.3 Million
Q4 2019 Jan 29, 2020	SELL	$42.0 - $48.25 $50,400 - $57,900	-1,200 Reduced 3.63%	31,823 $1.5 Million
Q2 2019 Jul 26, 2019	BUY	$39.4 - $42.7 $19,700 - $21,350	500 Added 1.54%	33,023 $1.32 Million
Q1 2019 Apr 09, 2019	SELL	$38.57 - $42.69 $30,663 - $33,938	-795 Reduced 2.39%	32,523 $1.36 Million
Q4 2018 Feb 12, 2019	SELL	$37.8 - $42.69 $18,862 - $21,302	-499 Reduced 1.48%	33,318 $1.27 Million
Q3 2018 Nov 07, 2018	BUY	$39.75 - $42.69 $4,014 - $4,311	101 Added 0.3%	33,817 $1.36 Million
Q2 2018 Sep 24, 2018	SELL	$39.61 - $42.76 $22,102 - $23,860	-558 Reduced 1.63%	33,716 $1.36 Million
Q1 2018 Sep 24, 2018	BUY	$36.18 - $40.15 $355,504 - $394,513	9,826 Added 40.19%	34,274 $1.34 Million
Q4 2017 Sep 24, 2018	BUY	$35.34 - $41.9 $863,992 - $1.02 Million	24,448	24,448 $867,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exeter Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exeter Financial, LLC with notifications on news.

Account